PT  - JOURNAL ARTICLE
AU  - Morgan, Helen
AU  - Gysling, Savannah
AU  - Navani, Neal
AU  - Baldwin, David
AU  - Hubbard, Richard
AU  - O’Dowd, Emma
TI  - Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset
AID  - 10.1136/thorax-2022-219593
DP  - 2024 Jan 01
TA  - Thorax
PG  - 83--85
VI  - 79
IP  - 1
4099  - http://thorax.bmj.com/content/79/1/83.short
4100  - http://thorax.bmj.com/content/79/1/83.full
SO  - Thorax2024 Jan 01; 79
AB  - Early changes in lung cancer care can affect survival. Given the decrease in diagnosis during lockdowns, we calculated their impact on survival using National Lung Cancer Audit data. Percentage survival and HRs for death were compared between 2019 and lockdown periods of 2020. Decreased survival was observed from the first national lockdown onwards and within 90 days of diagnosis. HRs were highest for people diagnosed at the end of 2020 at 1.26 (95% CI 1.20 to 1.32) for death within 90 days and 1.51 (95% CI 1.42 to 1.60) for death between 91 and 270 days. Further work is needed on measures to mitigate this impact.